We use cookies to analyze site traffic and improve your experience.
By accepting, you consent to the use of analytics cookies.

9766:TSEKONAMI Group Corporation Analysis

Data as of 2026-08-14 - not real-time

¥21,990.00

Latest Price

6/10Risk

Risk Level: Medium

Executive Summary

Konami Group Corporation trades at ¥21,990.00, with its moving averages tangled rather than clearly stacked — a neutral trend structure. Over a rolling month the price has gained 25.8%. Momentum indicators put RSI at 64.7 (approaching overbought) with MACD reading bullish. Price has been bracketed by support at ¥17,830.00 and resistance at ¥22,980.00.
Multiples put this in overvalued territory: 26.4 times earnings against the sector's 16.4. Sell-side targets cluster 19.3% above the current quote. Revenue is growing at 33.6% on a 21.4% profit margin. The 1.02% dividend yield looks covered by current payout levels.
Risk scores 6 out of 10, which is elevated for this asset class. With 30-day volatility of 52.0%, a beta of 0.19 and a maximum drawdown of 32.9%, position sizing matters here. The wider market backdrop reads extreme greed at 96 on the fear-greed composite.
Across every horizon the signals point the same way: hold, at a conviction of 3 out of 10.

Top Market Events

KONAMI GROUP’s Konami Gaming, Inc. First to Submit Manufacturer License Application in Japan’s Emerging IR Market

Market Outlook

Short Term

< 1 year
Neutral
Model confidence: 3/10

Key Factors

  • Trading above the 200-day average of 20518.25
  • MACD momentum is positive
  • 30-day price change of +25.8%

Medium Term

1–3 years
Neutral
Model confidence: 3/10

Key Factors

  • P/E of 26.4 versus sector average of 16.4
  • Trading above the 200-day average of 20518.25
  • Analyst targets imply +19.3% versus the current price

Long Term

> 3 years
Neutral
Model confidence: 3/10

Key Factors

  • P/E of 26.4 versus sector average of 16.4
  • Analyst targets imply +19.3% versus the current price
  • Profit margin of 21.4% is healthy

Key Metrics & Analysis

Financial Health

Revenue Growth33.60%
Profit Margin21.43%
P/E Ratio26.4
ROE21.16%
ROA14.45%
Debt/Equity9.49
P/B Ratio5.1
Op. Cash Flow¥141.5B
Free Cash Flow¥72.3B
Industry P/E16.4

Technical Analysis

TrendNeutral
RSI64.7
Support¥17,830.00
Resistance¥22,980.00
MA 20¥20,203.00
MA 50¥19,136.30
MA 200¥20,518.25
MACDBullish
VolumeDecreasing
Fear & Greed Index95.98

Valuation

Fair Value¥20,729.27
Target Price¥26,231.77
Upside/Downside19.29%
GradeOvervalued
TypeGrowth
Dividend Yield1.02%

Risk Assessment

Beta0.19
Volatility51.97%
Sector RiskMedium
Reg. RiskMedium
Geo RiskLow
Currency RiskMedium
Liquidity RiskLow

This analysis may contain inaccuracies and is provided for informational and research purposes only. It is not personal investment advice, a recommendation, or an instruction to buy, sell, or hold any asset.